PBYI - Puma Biotechnology, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - PBYI (1401667)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
42 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-08-12
PBYIMiller Michael PatrickDirS - Sale$3.49-23,35847,000-33%-$81,466
2024-07-17
PBYINougues Maximo FCFOS - Sale$3.70-4,156162,522-2%-$15,382
2024-07-17
PBYILudwig Jeffrey JeromeChief Commercial OfficerS - Sale$3.70-2,598118,388-2%-$9,615
2024-07-17
PBYIHunt Douglas MSee RemarksS - Sale$3.70-3,637133,227-3%-$13,461
2024-07-17
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$3.70-21,9207,063,5150%-$81,128
2024-07-02
PBYINougues Maximo FCFOS - Sale$3.27-5,295166,678-3%-$17,307
2024-07-02
PBYILudwig Jeffrey JeromeChief Commercial OfficerS - Sale$3.27-6,051120,986-5%-$19,778
2024-07-02
PBYIHunt Douglas MSee RemarksS - Sale$3.27-4,349136,864-3%-$14,215
2024-07-02
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$3.27-18,8857,085,4350%-$61,726
2024-06-13
PBYIWilson Troy EdwardDirS - Sale$3.33-27,000900-97%-$89,902
2024-06-13
PBYIStuglik Brian MDirS - Sale$3.39-9,90049,058-17%-$33,528
2024-06-13
PBYISenderowicz AdrianDirS - Sale$3.33-27,0000-100%-$89,818
2024-06-13
PBYIMoyes Jay MDirS - Sale$3.34-22,00021,322-51%-$73,467
2024-06-13
PBYIDorval AllisonDirS - Sale$3.37-11,00033,000-25%-$37,096
2023-12-04
PBYIWong Alvin FChief Scientific OfficerS - Sale$3.76-28097,9340%-$1,053
2024-01-03
PBYIWong Alvin FChief Scientific OfficerS - Sale$4.49-7,73398,214-7%-$34,689
2024-01-03
PBYILudwig Jeffrey JeromeChief Commercial OfficerS - Sale$4.49-12,95699,970-11%-$58,119
2024-01-03
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$4.49-41,3966,936,947-1%-$185,698
2024-01-03
PBYINougues Maximo FCFOS - Sale$4.49-15,682128,666-11%-$70,348
2024-01-03
PBYIHunt Douglas MSee RemarksS - Sale$4.49-8,358103,319-7%-$37,493
2023-11-07
PBYIMiller Michael PatrickDirS - Sale$2.83-25,00043,358-37%-$70,803
2023-07-03
PBYIWong Alvin FChief Scientific OfficerS - Sale$3.31-6,938105,947-6%-$22,973
2023-07-03
PBYINougues Maximo FCFOS - Sale$3.31-14,680144,348-9%-$48,608
2023-07-03
PBYILudwig Jeffrey JeromeChief Commercial OfficerS - Sale$3.31-12,103112,926-10%-$40,075
2023-07-03
PBYIHunt Douglas MSee RemarksS - Sale$3.31-7,809111,677-7%-$25,857
2023-07-03
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$3.31-60,6986,978,343-1%-$200,983
2023-06-13
PBYIWilson Troy EdwardDirS - Sale$3.45-27,00027,900-49%-$93,269
2023-06-13
PBYIMoyes Jay MDirS - Sale$3.45-22,00043,322-34%-$75,970
2023-06-13
PBYIStuglik Brian MDirS - Sale$3.46-9,90058,958-14%-$34,252
2023-06-13
PBYISenderowicz AdrianDirS - Sale$3.45-27,00027,000-50%-$93,280
2023-06-13
PBYIDorval AllisonDirS - Sale$3.45-10,00044,000-19%-$34,500
2023-06-13
PBYIMiller Michael PatrickDirS - Sale$3.45-13,50068,358-16%-$46,630
2023-06-02
PBYIWong Alvin FChief Scientific OfficerS - Sale$3.45-269112,8850%-$928
2023-01-03
PBYIWong Alvin FChief Scientific OfficerS - Sale$4.18-3,46054,553-6%-$14,456
2023-01-03
PBYINougues Maximo FCFOS - Sale$4.18-10,499100,427-9%-$43,864
2023-01-03
PBYILudwig Jeffrey JeromeChief Commercial OfficerS - Sale$4.18-6,56858,057-10%-$27,440
2023-01-03
PBYIHunt Douglas MSee RemarksS - Sale$4.18-4,22571,350-6%-$17,652
2023-01-03
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$4.18-27,2416,852,6380%-$113,810
2022-12-02
PBYIAuerbach Alan HPres, CEO, 10%S - Sale$4.50-1,2516,311,6980%-$5,627
2022-12-02
PBYIHunt Douglas MSee RemarksS - Sale$4.50-42975,575-1%-$1,930
2022-12-02
PBYINougues Maximo FCFOS - Sale$4.50-159110,9260%-$715
2022-12-02
PBYIWong Alvin FChief Scientific OfficerS - Sale$4.50-51458,013-1%-$2,312

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top